Page last updated: 2024-10-28

hydroxyurea and Leukemia, Myelogenous, Aggressive Phase

hydroxyurea has been researched along with Leukemia, Myelogenous, Aggressive Phase in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (55.56)18.2507
2000's3 (33.33)29.6817
2010's0 (0.00)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Christiansen, JS1
Gaddh, M1
Wells, J1
Huang, Q1
Goldman, JM1
Bourantas, KL1
Syrou, M1
Tsiara, S1
Danella, M1
Konstantinides, P1
Girinsky, T1
Bonomi, M1
Bayle, C1
Polák, J1
Koza, V1
Cetkovský, P1
Haskovec, C1
Wassmann, B1
Klein, SA1
Scheuring, U1
Pfeifer, H1
Martin, H1
Gschaidmeier, H1
Hoelzer, D1
Ottmann, OG1
Kapoor, N1
Keever, CA1
Hsu, SH1
Copelan, EA1
Tutschka, PJ1
Nese, M1

Reviews

1 review available for hydroxyurea and Leukemia, Myelogenous, Aggressive Phase

ArticleYear
Management of chronic myeloid leukaemia.
    Blood reviews, 1994, Volume: 8, Issue:1

    Topics: Actuarial Analysis; Adolescent; Adult; Aged; Blast Crisis; Bone Marrow Transplantation; Busulfan; Ch

1994

Trials

1 trial available for hydroxyurea and Leukemia, Myelogenous, Aggressive Phase

ArticleYear
[Therapy of chronic myeloid leukemia with interferon, alone or combined. Preliminary experience].
    Sangre, 1991, Volume: 36, Issue:5

    Topics: Adolescent; Adult; Aged; Busulfan; Combined Modality Therapy; Female; Humans; Hydroxyurea; Immunolog

1991

Other Studies

7 other studies available for hydroxyurea and Leukemia, Myelogenous, Aggressive Phase

ArticleYear
An uncommon presentation of chronic myeloid leukemia.
    Annals of hematology, 2020, Volume: 99, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dasatinib; Dilatation, Pathologic; Humans; Hy

2020
Chronic myelogenous leukemia in accelerated phase.
    Archives of pathology & laboratory medicine, 2005, Volume: 129, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Benzamides; Chromosome

2005
Combination therapy with interferon alfa-2b and hydroxyurea during the accelerated phase of chronic myelogenous leukemia.
    Acta haematologica, 1996, Volume: 95, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Hydroxyurea; Interferon

1996
Long-term response in accelerated-phase chronic myelogenous leukemia with protracted splenic irradiation and alpha-interferon.
    American journal of hematology, 1999, Volume: 62, Issue:4

    Topics: Adult; Antineoplastic Agents; Humans; Hydroxyurea; Interferon-alpha; Leukemia, Myelogenous, Chronic,

1999
An accelerrated-phase CML patient with e19a2 junction of BCR/ABL gene - the first case of transplanted CML with micro bcr.
    Bone marrow transplantation, 2000, Volume: 25, Issue:10

    Topics: Abortion, Therapeutic; Adult; Antineoplastic Agents, Alkylating; Bone Marrow Transplantation; Diseas

2000
Hematologic and cytogenetic remission by STI571 (Glivec) in a patient relapsing with accelerated phase CML after second allogeneic stem cell transplantation.
    Bone marrow transplantation, 2001, Volume: 28, Issue:7

    Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Benzamides; Bone Marrow Transplantation; C

2001
Prolonged remission of accelerated phase Philadelphia chromosome negative chronic myeloid leukemia following autologous recovery of normal hematopoietic elements after busulfan/cyclophosphamide and allogeneic marrow transplantation.
    Bone marrow transplantation, 1992, Volume: 9, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantat

1992
chemdatabank.com